United States Typhoid Fever Market Outlook: Antibiotics, Resistance, and Regional Dynamics | Emergent, Bharat Biotech, Bio Med, Sanofi.

-> Typhoid fever is an infectious disease caused by Salmonella typhi; an indistinguishable condition called paratyphoid fever is caused by a related serotype. Both diseases are transmitted through ingestion of contaminated food or water. Symptoms include prolonged fever, fatigue, abdominal pain, and gastrointestinal disturbances. Diagnosis is confirmed through blood, stool, or urine cultures. Treatment typically involves antibiotics; however, resistance patterns should be considered when selecting therapy.

-> Preventive measures include vaccination, improved sanitation, and access to clean water. The World Health Organization recommends vaccination during outbreaks and in endemic areas. Several vaccines are available, including the oral Ty21a and the injectable Vi polysaccharide vaccines. Control strategies focus on improving hygiene and sanitation infrastructure to reduce transmission risks.

Market Size and Growth

According to the DataM Intelligence: The global typhoid fever market size reached US$ 373.72 Million in 2024 and is expected to reach US$ 858.77 Million by 2033, growing at a CAGR of 9.7% during the forecast period 2025-2033.

Analyst Concludes: The global typhoid fever landscape remains a significant public health concern due to persistent transmission through contaminated food and water. Rising antibiotic resistance underscores the need for careful therapeutic selection, while the availability of oral and injectable vaccines presents viable preventive strategies. Investment in sanitation infrastructure, vaccination programs, and targeted awareness campaigns is essential to mitigate disease burden, particularly in endemic regions, positioning both treatment and prevention measures as critical growth drivers in the typhoid fever market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/typhoid-fever-market?sb

Key Development:

✅ In May 2025, Lucintel reported that the typhoid fever vaccine market in Japan shows promising prospects in various sectors, including hospitals, clinics, and specialty centers. This indicates a growing infrastructure to support vaccine distribution.

✅ In February 2024, SK bioscience's SKYTyphoid received World Health Organization (WHO) prequalification. This single-dose vaccine demonstrated strong immunogenicity and safety in children as young as six months, following successful Phase III trials in the Philippines and Nepal. The prequalification facilitates global procurement, addressing urgent demand in endemic regions.

✅ In October, 2024, Zydus Lifesciences' ZyVac TCV achieved WHO prequalification. Similar to SKYTyphoid, it is administered as a single dose and approved for children aged six months and older. Clinical studies have shown its immune response profile and safety to be comparable to that of Typbar TCV.

Key Players:

=> Top companies in the typhoid fever market include Pfizer Inc., F. Hoffmann-La Roche Ltd, Bayer AG, DAIICHI SANKYO COMPANY, LIMITED., GSK plc., AstraZeneca, Merck & Co., Inc., AbbVie Inc., Sanofi., Johnson & Johnson among others.

Growth Forecast Projected:

The Global Typhoid Fever Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Typhoid Fever Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=typhoid-fever-market

Key Segments:

➥ By Type: Live Attenuated Vaccine, Monovalent Typhoid Vaccines, Capsular Polysaccharide Vaccines, Conjugate Vaccine, Others

➥ By Route of Administration: Oral, Parenteral

➥ By End-Users: Hospitals, Specialty Clinics, Others

Regional Analysis for Typhoid Fever Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Typhoid Fever producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Typhoid Fever revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/typhoid-fever-market?sb

FAQ

What is the current size of the Typhoid Fever Market?

A: In 2024, the Typhoid Fever Market was valued at US$ 373.72 Million, reflecting its strong industry presence.

Q2: How large is the Typhoid Fever Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Typhoid Fever Market will grow to around US$ 858.77 Million , demonstrating significant expansion.

Q3: What is the growth rate of the Typhoid Fever Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 9.7% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.